Cannabis
Mexican Senate Passes Bill To Legalize Marijuana Nationwide (Marijuana Moment)
Israel Announced Intentions To Legalize Recreational Cannabis (High Times)
Argentina redraws medical cannabis rules, allowing home cultivation (Marijuana Business Daily)
Cannabis resin now 25% more potent, global study reveals (The Guardian)
New Jersey Senate Approves Marijuana Decriminalization Despite Contentious Psychedelics Provision (Marijuana Moment)
CBD is not a narcotic, says EU court as it rules French ban is illegal (The Guardian)
Lawmakers In Wisconsin Capital Vote To Allow Marijuana Use In Public (Marijuana Moment)
How marijuana legalization made strides across the US in this election (The Guardian)
New Jersey Senate And Assembly Committee Pass Marijuana Sales Bills Despite Pushback From Equity Advocates (Marijuana Moment)
New Jersey: Senate Lawmakers Approve Legislation to End Low-Level Marijuana Arrests (NORML)
LSD
Joanna Harcourt-Smith, Lover of Timothy Leary, High Priest of LSD, Dies at 74 (The New York Times)
MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities (Psilocybin Alpha)
Florida man on LSD tackles Disney security guard at Animal Kingdom (Orlando Weekly)
Magic Mushrooms
First Non-Palliative Canadian Granted Access To Psilocybin Therapy (Psilocybin Alpha)
Usona Offers Psilocybin to Eligible Researchers at No Cost (Usona Institute)
Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics (Psilocybin Alpha)
Psilocybin increases the expression neuroplasticity-related genes in rats (PsyPost)
Psilocybin for Depression Study Approved and Funded by German Government (Psilocybin Alpha)
Pilot Study of Psilocybin-Assisted Group Therapy in Older AIDS Survivors (Psychedelic Science Review)
Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks (Psilocybin Alpha)
Aeruginascin Identified in Psilocybe cubensis Magic Mushrooms (Psychedelic Science Review)
NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss (Psilocybin Alpha)
How will Oregon’s new psilocybin therapy program work? (OPB)
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders (Psilocybin Alpha)
ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration (Psychedelic Science Review)
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program (Psilocybin Alpha)
Ketamine
Happiness during ketamine infusion predicts treatment-resistant depression outcomes (Healio)
Ketamine May Be Helpful in Treating Alcohol Use Disorder (Psychology Today)
Veterans Are Using Ketamine-Assisted Psychotherapy To Help With PTSD (Green Entrepreneur)
Miscellaneous
Vancouver proposes decriminalizing possession of small amounts of drugs (The Globe and Mail)
Canadian Officials Respond To Psychedelics Decriminalization Petition, Saying No Legal Changes Needed (Marijuana Moment)
UK on the Brink of a Psychedelic Therapy Revolution (Filter)
One Simple Way Biden Could Prove He Regrets His Role in the Drug War (Slate)
How Tripping Can Help Us Reimagine Capitalism Ahead of Psychedelic Commercialization (DoubleBlind)
High Country: The Aspen Brain Institute examines the promising future of psychedelic-assisted therapy (The Aspen Times)
The Oregon Model (The Baffler)
Keys for Integrating Psychedelic Experiences (Psychedelics Today)
Kin Spruijt: A Psychedelic Nurse in a Dutch Psychiatric Clinic (Chacruna)
Paraphernalia Decrim Advances in DC—Just Not for Drug Sellers (Filter)
Breaking Barriers So Psychedelic Experiences Can Become Mainstream (Forbes)
What is the Default Mode Network? (Psychedelic Science Review)
Avoiding Negative Experiences With Microdosing (The Third Wave)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.